Latest immunotherapy news
Omalizumab, Multiallergen OIT Both Viable for Multifood Allergy Treatment
posted August 3rd
by modernClinician Editorial Team
by modernClinician Editorial Team
Enfortumab Vedotin-Pembrolizumab More Effective for MIBC Than Cisplatin-Gemcitabine
posted July 28th
by modernClinician Editorial Team
by modernClinician Editorial Team
Indefinite-Duration Maintenance Therapy No Better Than Fixed-Duration Therapy in Multiple Myeloma
posted July 23rd
by modernClinician Editorial Team
by modernClinician Editorial Team
Rituximab Noninferior to Ocrelizumab for Newly Diagnosed Relapsing MS
posted July 6th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Thymic Radiation Linked to Worse Outcomes in Patients With NSCLC 
Extreme Heat Linked to 33 Clinically Reportable Diagnoses 
Paternal Exposure to Valproate Not Linked to Offspring Neurodevelopmental Disorders 
Drug Retention in Spondyloarthritis Varies With Socioeconomic Status Related Articles
Preoperative Chemo + Immunotherapy Combo Shrinks Head, Neck Cancer Tumors 
Cretostimogene Promising for High-Risk, Non-Muscle-Invasive Bladder Cancer 
Aglatimagene Besadenovec + Valacyclovir Ups DFS in Localized Prostate Cancer 
Subset of Patients With Follicular Lymphoma Can Achieve Cure With CHOP-Based Chemoimmunotherapy Monthly Specialist Briefings
Stay Connected
